tiprankstipranks
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
US Market

CytomX Therapeutics (CTMX) Income Statement

Compare
620 Followers

CytomX Therapeutics Income Statement

Last quarter (Q3 2024), CytomX Therapeutics's total revenue was $33.43M, an increase of 26.71% from the same quarter last year. In Q3, CytomX Therapeutics's net income was $5.74M. See CytomX Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 101.21M$ 53.16M$ 69.57M$ 100.36M$ 57.49M
Gross Profit
$ 101.21M$ 47.31M$ 63.73M$ 100.36M$ 57.49M
Operating Expenses
$ 107.70M$ 154.50M$ 153.35M$ 148.97M$ 168.38M
Depreciation and Amortization
$ 2.17M$ 5.86M$ 5.84M$ 5.46M$ 2.60M
EBITDA
$ -4.31M$ -98.89M$ -113.34M$ -77.97M$ -138.88M
Operating Income
$ -6.48M$ -101.33M$ -83.78M$ -48.60M$ -110.89M
Other Income/Expenses
$ 9.81M$ 2.02M$ 172.00K$ 1.81M$ 8.23M
Pretax Income
$ 3.32M$ -99.32M$ -83.61M$ -46.80M$ -102.67M
Net Income
$ -569.00K$ -97.30M$ -80.65M$ -32.88M$ -102.24M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.01$ -1.48$ -1.26$ -0.71$ -2.26
Diluted EPS
$ -0.01$ -1.48$ -1.26$ -0.71$ -2.26
Weighted Average Shares Outstanding
73.81M 65.74M 64.15M 46.15M 45.34M
Weighted Average Shares Outstanding (Diluted)
73.81M 65.74M 64.15M 46.15M 45.34M
Currency in USD

CytomX Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis